1
LEE Kwangho, NIU Deqiang, PETTER Russell C, SINGH Juswinder: COMPOSÉS HÉTÉROARYLE ET LEURS UTILISATIONS, HETEROARYL COMPOUNDS AND USES THEREOF. AVILA THERAPEUTICS, LEE Kwangho, NIU Deqiang, PETTER Russell C, SINGH Juswinder, BUTEAU Kristen C, May 10, 2012: WO/2012/061303 (33 worldwide citation)

Heterocyclic pynmidine compounds that modulate mutant-selective epidermal growth factor receptor (EGFR) kinase activity are disclosed. Selectivity in modulation of various EGFR mutant activity has been disclosed. Pharmaceutical compositions comprising the pynmidine derivative, and methods of treatme ...


2

3
LEE Kwangho, NIU Deqiang, PETTER Russell C, BAEVSKY Matthew Frank, SINGH Juswinder: COMPOSÉS HÉTÉROCYCLIQUES ET LEURS UTILISATIONS, HETEROCYCLIC COMPOUNDS AND USES THEREOF. AVILA THERAPEUTICS, LEE Kwangho, NIU Deqiang, PETTER Russell C, BAEVSKY Matthew Frank, SINGH Juswinder, BUTEAU Kristen C, May 10, 2012: WO/2012/061299 (32 worldwide citation)

Heterocyclic pyrimidine compounds that modulate mutant-selective epidermal growth factor receptor (EGFR) kinase activity are disclosed. Selectivity in inhibition of various mutant-EGFR is disclosed. Pharmaceutical compositions containing the pyrimidine derivatives, and methods of treating diseases a ...


4
LAI Mei, WITOWSKI Steven Richard, TESTER Richland Wayne, LEE Kwangho: [fr] SELS DINHIBITEUR DE KINASES DU RÉCEPTEUR DE FACTEUR DE CROISSANCE ÉPIDERMIQUE, [en] SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR. CELGENE AVILOMICS RESEARCH, BUTEAU Kristen C, September 19, 2013: WO/2013/138502 (7 worldwide citation)

[en] The present invention provides a salt form and compositions thereof, which are useful as an inhibitor of EGFR kinases and which exhibits desirable characteristics for the same.


5
Hurley Timothy Brian, Lee Kwangho, Peukert Stefan, Wattanasin Sompong: Inhibitors of undecaprenyl pyrophosphate synthase. Novartis, Novartis, Pharma, Hurley Timothy Brian, Lee Kwangho, Peukert Stefan, Wattanasin Sompong, ALEXANDER John B, January 31, 2008: WO/2008/014307 (3 worldwide citation)

The present invention relates to compounds that are selective and/or potent inhibitors of UPPS. In addition to compounds which inhibit UPPS, the invention also provides pharmaceutical compositions comprising these compounds and methods of using these compounds for treating bacterial disease, such as ...


6
Bracken Kathryn Rene, Bushell Simon, Dean Karl, Francavilla Charles, Jain Rakesh K, Lee Kwangho, Seepersaud Mohindra, Shu Lei, Sundaram Arathia, Yuan Zhengyu: N - formyl hydroxylamine compounds as pdf inhibitors. Novartis, Novartis, Pharma, Vicuron Pharmaceuticals, Bracken Kathryn Rene, Bushell Simon, Dean Karl, Francavilla Charles, Jain Rakesh K, Lee Kwangho, Seepersaud Mohindra, Shu Lei, Sundaram Arathia, Yuan Zhengyu, BAUTISTA Regina S, November 30, 2006: WO/2006/127576 (2 worldwide citation)

Novel N-formyl hydroxylamine compounds (I) and their derivatives are disclosed. These N-formyl hydroxylamine compounds inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes . The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display selective i ...


7

8
Doan Diem H, Wong Yung Seng, Desai Anil, Nguyen Andrews, Susset Dieter, Lee Kwangho, Jiang Wei Chuan, Agarwal Anoop: (bios) Program storage on a motherboard for a variety of computer cpu types. Epson Portland, CAROTHERS W Douglas Jr, April 29, 1993: WO/1993/008532 (1 worldwide citation)

A microcomputer system, according to an embodiment of the present invention, comprises a motherboard with sockets for EISA add-on boards and a processor board. The BIOS program for the processor board is stored on the motherboard, in a flash memory. A permanent BIOS program, also on the motherboard, ...


9
Bracken Kathryn Rene, Bushell Simon, Dean Karl, Francavilla Charles, Jain Rakesh K, Lee Kwangho, Seepersaud Mohindra, Shu Lei, Sundaram Arathia, Yuan Zhengyu: N-formyl hydroxylamine compounds as pdf inhibitor. Novartis, huangge sheng anpei dong, June 4, 2008: CN200680018118

Novel N-formyl hydroxylamine compounds and their derivatives are disclosed. These N-formyl hydroxylamine compounds inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibi ...


10
Hurley Timothy Brian, Lee Kwangho, Peukert Stefan, Wattanasin Sompong: Inhibitors of undecaprenyl pyrophosphate synthase. Novartis, May 20, 2009: EP2059305-A2

The present invention relates to compounds that are selective and/or potent inhibitors of UPPS. In addition to compounds which inhibit UPPS, the invention also provides pharmaceutical compositions comprising these compounds and methods of using these compounds for treating bacterial disease, such as ...